Renal Recovery in Dialysis-Dependent Crescentic IgA Vasculitis: Abbreviated Cyclophosphamide and Rituximab-Based Induction in an Older Patient (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO0524; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Induction consisted of pulse methylprednisolone and a single IV CYC dose. This patient's striking improvement following abbreviated CYC exposure and RTX transition suggests prolonged alkylating agent courses may not be absolute prerequisites in selected patients with severe IgAV nephritis. In a population where dialysis-dependent crescentic IgAV is historically associated with poor renal survival, this case reinforces that prompt aggressive immunosuppression can yield durable recovery and contributes to the emerging, though still limited, literature supporting B-cell depletion in severe IgA-mediated disease."
Clinical • Chronic Kidney Disease • Gastroenterology • Gastrointestinal Disorder • Inflammation • Musculoskeletal Pain • Nephrology • Renal Disease • Vasculitis
|
|
Adam Krieger; Matthew Pittappilly
|